NewAmsterdam Pharma Co N.V annual free cash flow
2021
2022
2023
2024
2025
NewAmsterdam Pharma Co N.V Free Cash Flow (FCF) History (NAMS)
NewAmsterdam Pharma Co N.V reported −$148.0M in free cash flow for fiscal 2025, an increase of $11.2M from the previous fiscal year, with a free cash flow margin of −657.82%.
View full NewAmsterdam Pharma Co N.V company overviewNewAmsterdam Pharma Co N.V free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | −$148.0M | $11.2M | — | −657.82% |
| 2024 | 2024-12-31 | −$159.2M | −$18.0M | — | −349.49% |
| 2023 | 2023-12-31 | −$141.2M | −$151.7M | — | −1002.43% |
| 2022 | 2022-12-31 | $10.4M | $40.0M | — | +10.17% |
| 2021 | 2021-12-31 | −$29.5M | — | — | — |
NewAmsterdam Pharma Co N.V quarterly free cash flow
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$39.3M | −$1.5M | — | −1061.71% |
| Q1 2026 | 2026-03-31 | −$30.6M | $5.8M | — | −1007.96% |
| Q4 2025 | 2025-12-31 | −$41.0M | −$3.5M | — | −128046.88% |
| Q3 2025 | 2025-09-30 | −$32.8M | −$20.2M | — | −9428.45% |
| Q2 2025 | 2025-06-30 | −$37.8M | $16.4M | — | −197.23% |
| Q1 2025 | 2025-03-31 | −$36.5M | $18.5M | — | −1225.12% |
| Q4 2024 | 2024-12-31 | −$37.5M | −$4.4M | — | −293.49% |
| Q3 2024 | 2024-09-30 | −$12.6M | $34.4M | — | −43.20% |
| Q2 2024 | 2024-06-30 | −$54.2M | −$24.9M | — | −2377.71% |
| Q1 2024 | 2024-03-31 | −$55.0M | −$23.1M | — | −3924.84% |
| Q4 2023 | 2023-12-31 | −$33.1M | — | — | −4119.18% |
| Q3 2023 | 2023-09-30 | −$47.0M | — | — | −1597.59% |
| Q2 2023 | 2023-06-30 | −$29.3M | — | — | −1707.05% |
| Q1 2023 | 2023-03-31 | −$31.9M | — | — | −369.34% |
NewAmsterdam Pharma Co N.V free cash flow growth trends
NewAmsterdam Pharma Co N.V's latest reported quarter, Q2 2026, generated −$39.3M in free cash flow, a decrease of $1.5M year over year.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review NewAmsterdam Pharma Co N.V filings at SEC.gov ↗